Product Information
FORFIVO XL 450 MG TABLET is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $14.9834 per EA under NDC 24979024706. Its NADAC has been published 42 times since Oct 30, 2024.
FDA first approved this application on Nov 10, 2011.
The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
450 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979024706
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
10/30/2024
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022497FDA Approved
11/10/2011
On Market Since
12/15/2023
Pharmacological Classes
Price Statistics
The NADAC for FORFIVO XL 450 MG TABLET has been published 42 times since Oct 30, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9834 per EA |
|---|---|
| All-time high | $14.9834 (Aug 13, 2025) |
| All-time low | $14.9834 (Oct 30, 2024) |
| Median price | $14.9834 |
| Average price | $14.9834 |
| Largest weekly change | 0.0% (Nov 6, 2024) |
| Weeks tracked | 42 |
| Tracking since | Oct 30, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Aug 13, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FORFIVO XL 450 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FORFIVO XL 450 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $14.9834 per EA (NDC 24979024706), effective Aug 13, 2025.
How has the price of FORFIVO XL 450 MG TABLET changed over time?
Over the history we have for it, the NADAC for FORFIVO XL 450 MG TABLET has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Oct 30, 2024.
What are the highest and lowest recorded NADAC prices for FORFIVO XL 450 MG TABLET?
Since Oct 30, 2024, the NADAC for FORFIVO XL 450 MG TABLET has ranged from a low of $14.9834 (Oct 30, 2024) to a high of $14.9834 (Aug 13, 2025), with a median of $14.9834 per EA.
Are there cheaper alternatives to FORFIVO XL 450 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 450 MG TABLET, is $7.5194 per EA — about 50% below FORFIVO XL 450 MG TABLET.
Who manufactures FORFIVO XL 450 MG TABLET?
FORFIVO XL 450 MG TABLET (NDC 24979024706) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.